Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

Status:
Active, not recruiting

Trial end date:
2021-10-01

Target enrollment:

Participant gender:

To investigate the efficacy of treatment with oral trofinetide versus placebo in females with Rett syndrome

Phase 3

ACADIA Pharmaceuticals Inc.

Pharmaceutical Solutions